Guideline

Federation of Infectious Diseases Societies of Southern Africa guideline: Recommendations for the detection, management and prevention of healthcare-associated Candida auris colonisation and disease in South Africa

Nelesh P. Govender, Theunis Avenant, Adrian Brink, Vindana Chibabhai, Joy Cleghorn, Briette du Toit, Chetna Govind, Elsie Lewis, Warren Lowman, Hleziphi Mahlangu, Caroline Maslo, Angeliki Messina, Mervyn Mer, Kim Pieton, Sharona Seetharam, Charlotte Sriruttan, Karin Swart, Erika van Schalkwyk
Southern African Journal of Infectious Diseases | Vol 34, No 1 | a163 | DOI: https://doi.org/10.4102/sajid.v34i1.163 | © 2019 Nelesh P. Govender, Theunis Avenant, Adrian Brink, Vindana Chibabhai, Joy Cleghorn, Briette du Toit, Chetna Govind, Elsie Lewis, Warren Lowman, Hleziphi Mahlangu, Caroline Maslo, Angeliki Messina, Mervyn Mer, Kim Pieton, Sharona Seetharam, Charlotte Sriru | This work is licensed under CC Attribution 4.0
Submitted: 04 June 2019 | Published: 26 September 2019

About the author(s)

Nelesh P. Govender, National Institute for Communicable Diseases, Centre for Healthcare-Associated Infections, Antimicrobial Resistance and Mycoses, Division of the National Health Laboratory Service, Johannesburg, South Africa; Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; and Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa
Theunis Avenant, Kalafong Provincial Tertiary Hospital and Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa
Adrian Brink, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa; and Ampath Laboratories, Cape Town, South Africa
Vindana Chibabhai, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; National Health Laboratory Service, Johannesburg, South Africa; and Charlotte Maxeke Johannesburg Academic Hospital, Johannesburg, South Africa
Joy Cleghorn, Life Healthcare Group, Johannesburg, South Africa
Briette du Toit, Mediclinic Southern Africa, Cape Town, South Africa
Chetna Govind, Lancet Laboratories, Durban, South Africa
Elsie Lewis, Steve Biko Pretoria Academic Hospital, Pretoria, South Africa
Warren Lowman, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; and WITS Donald Gordon Medical Centre and Vermaak and Partners Pathologists, Johannesburg, South Africa
Hleziphi Mahlangu, Clinix Health Group, Johannesburg, South Africa
Caroline Maslo, Netcare Hospitals Limited, Johannesburg, South Africa
Angeliki Messina, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; and Netcare Hospitals Limited, Johannesburg,, South Africa
Mervyn Mer, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; and Charlotte Maxeke Johannesburg Academic Hospital, Johannesburg, South Africa
Kim Pieton, Chris Hani Baragwanath Academic Hospital, Johannesburg, South Africa
Sharona Seetharam, Lancet Laboratories, Cape Town, South Africa
Charlotte Sriruttan, National Institute for Communicable Diseases [Centre for Healthcare-Associated Infections, Antimicrobial Resistance and Mycoses], a Division of the National Health Laboratory Service, Johannesburg, South Africa; and Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
Karin Swart, Netcare Hospitals Limited, Johannesburg, South Africa
Erika van Schalkwyk, National Institute for Communicable Diseases [Centre for Healthcare-Associated Infections, Antimicrobial Resistance and Mycoses], a Division of the National Health Laboratory Service, Johannesburg, South Africa

Abstract

Candida auris has been detected at almost 100 South African hospitals, causing large outbreaks in some facilities, and this pathogen now accounts for approximately 1 in 10 cases of candidaemia. The objective of this guideline is to provide updated, evidence-informed recommendations outlining a best-practice approach to prevent, diagnose and manage C. auris disease in public- and private-sector healthcare settings in South Africa. The 18 practical recommendations cover five focus areas: laboratory identification and antifungal susceptibility testing, surveillance and outbreak response, infection prevention and control, clinical management and antifungal stewardship.

Keywords

Candida auris; Candidaemia; Infection Control; Antifungal Treatment; Diagnosis; Antifungal Stewardship.

Metrics

Total abstract views: 9727
Total article views: 13299

 

Crossref Citations

1. Environmental Clonal Spread of Azole-Resistant Candida parapsilosis with Erg11-Y132F Mutation Causing a Large Candidemia Outbreak in a Brazilian Cancer Referral Center
Danilo Y. Thomaz, João N. de Almeida, Odeli N. E. Sejas, Gilda M. B. Del Negro, Gabrielle O. M. H. Carvalho, Viviane M. F. Gimenes, Maria Emilia B. de Souza, Amir Arastehfar, Carlos H. Camargo, Adriana L. Motta, Flávia Rossi, David S. Perlin, Maristela P. Freire, Edson Abdala, Gil Benard
Journal of Fungi  vol: 7  issue: 4  first page: 259  year: 2021  
doi: 10.3390/jof7040259

2. In Vitro Antifungal Resistance of Candida auris Isolates from Bloodstream Infections, South Africa
Tsidiso G. Maphanga, Serisha D. Naicker, Stanford Kwenda, Jose F. Muñoz, Erika van Schalkwyk, Jeannette Wadula, Trusha Nana, Arshad Ismail, Jennifer Coetzee, Chetna Govind, Phillip S. Mtshali, Ruth S. Mpembe, Nelesh P. Govender
Antimicrobial Agents and Chemotherapy  vol: 65  issue: 9  year: 2021  
doi: 10.1128/AAC.00517-21

3. Candida auris — a New Pathogen of Nosocomial Infections
T. V. Chernenkaya
Russian Sklifosovsky Journal "Emergency Medical Care"  vol: 13  issue: 2  first page: 258  year: 2024  
doi: 10.23934/2223-9022-2024-13-2-258-263

4. Clinical Efficacy and Safety of a Novel Antifungal, Fosmanogepix, in Patients with Candidemia Caused by Candida auris : Results from a Phase 2 Trial
Jose A. Vazquez, Peter G. Pappas, Kenneth Boffard, Fathima Paruk, Paul A. Bien, Margaret Tawadrous, Eric Ople, Pamela Wedel, Iwona Oborska, Michael R. Hodges
Antimicrobial Agents and Chemotherapy  vol: 67  issue: 5  year: 2023  
doi: 10.1128/aac.01419-22

5. First report of infections due to Candidozyma (formerly Candida ) auris in Botswana, 2022–2024
Teresia W. Gatonye, Tichaona Machiya, Janet John-Thubuka, Jack Mkubwa, Tlhalefo D. Ntereke, Tshiamo Zankere, Kwana Lechiile, Chimwemwe Viola Tembo, Boingotlo Gopolang, Kabelo Zwinila, Celda Tiroyakgosi, Naledi Mannathoko, Margaret Mokomane, Daniel Loeto, Miriam Mwamba, Rudzani Mashau, Ruth Mpembe, Silondiwe Nzimande, Nelesh P. Govender, David M. Goldfarb, Ebbing Lautenbach, Susan Coffin, Britt Nakstad, Jonathan Strysko, Melissa Richard-Greenblatt, Paschalis Vergidis
Microbiology Spectrum  vol: 13  issue: 10  year: 2025  
doi: 10.1128/spectrum.02042-25

6. Candida auris Clinical Isolates Associated with Outbreak in Neonatal Unit of Tertiary Academic Hospital, South Africa
Dikeledi Kekana, Serisha D. Naicker, Liliwe Shuping, Sithembiso Velaphi, Firdose L. Nakwa, Jeannette Wadula, Nelesh P. Govender
Emerging Infectious Diseases  vol: 29  issue: 10  year: 2023  
doi: 10.3201/eid2910.230181

7. Bacteria and yeasts of nosocomial importance in a radiology department in an academic hospital
Rodger P. Osmond, Susan Lucas, Rispah N. Chomba
Southern African Journal of Infectious Diseases  vol: 40  issue: 1  year: 2025  
doi: 10.4102/sajid.v40i1.703

8. The laboratory investigation, management, and infection prevention and control of Candida auris: a narrative review to inform the 2024 national guidance update in England
Christopher R. Jones, Claire Neill, Andrew M. Borman, Emma L. Budd, Martina Cummins, Carole Fry, Rebecca L. Guy, Katie Jeffery, Elizabeth M. Johnson, Rohini Manuel, Mariyam Mirfenderesky, Ginny Moore, Bharat Patel, Silke Schelenz, Karren Staniforth, Surabhi K. Taori, Colin S. Brown
Journal of Medical Microbiology   vol: 73  issue: 5  year: 2024  
doi: 10.1099/jmm.0.001820

9. Mechanisms of resistance to cell wall and plasma membrane targeting antifungal drugs in Candida species isolated in Africa
Chibuike Ibe, Akaninyene Otu, Carolina Henritta Pohl
Expert Review of Anti-infective Therapy  vol: 23  issue: 1  first page: 91  year: 2025  
doi: 10.1080/14787210.2024.2448844